Enrollment (n = 80)

Assessed for eligibility (n = 36)

Not meeting inclusion criteria (n = 4)

Declined to participate (n = 2)

Other reasons (n = 2)

Randomized (n = 28)

Group I (Control)

Placebo patch + Essix

Allocated (n = 14)

Received (n = 14)

Boswellia patch

Allocated (n = 14)

Received (n = 14)

Lost to follow-up: 0

Discontinued: 0

Lost to follow-up: 0

Discontinued: 0

Analyzed (n = 14)

Excluded (n = 0)

Analyzed (n = 14)

Excluded (n = 0)

Alloca-

Follow-Up

Analysis